BamSEC and AlphaSense Join Forces
Learn More

Protalix BioTherapeutics Inc.

NYSE American: PLX    
Share price (8/12/25): $1.64    
Market cap (8/12/25): $131 million
Search in Documents
Key Exhibits
External Links

Underwriting Agreements Filter

EX-1.1
from 8-K 3 pages ​ ​ March 17, 2025 ​ Protalix Biotherapeutics, Inc. 2 University Plaza, Suite 100 Hackensack, New Jersey 07601 Attention: Eyal Rubin, Chief Financial Officer ​ Dear Mr. Rubin: ​
12/34/56
EX-1.1
from 8-K 29 pages Protalix Biotherapeutics, Inc. Common Stock ($0.001 Par Value) at the Market Offering Agreement
12/34/56
EX-1.1
from 8-K 3 pages ​ ​ May 2, 2022 ​ Protalix BioTherapeutics 2 University Plaza, Suite 100 Hackensack, New Jersey 07601 Attention: Eyal Rubin, Chief Financial Officer ​ Dear Mr. Rubin: ​
12/34/56
EX-1.1
from 8-K 30 pages Protalix Biotherapeutics, Inc. Common Stock ($0.001 Par Value) at the Market Offering Agreement
12/34/56
EX-1.1
from 8-K 37 pages Protalix Biotherapeutics, Inc. (A Delaware Corporation) 7,608,695 Shares of Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 29 pages Protalix Biotherapeutics, Inc. Common Stock ($0.001 Par Value) Atm Equity Offeringsm Sales Agreement
12/34/56
EX-1
from SC 13G/A 1 page Exhibit 1 Joint Filing Agreement
12/34/56
EX-1
from SC 13G/A 1 page Exhibit 1 Joint Filing Agreement
12/34/56
EX-1
from SC 13G 1 page Exhibit 1 Joint Filing Agreement
12/34/56
EX-1.1
from 8-K 36 pages Protalix Biotherapeutics, Inc. 4,500,000 Shares Common Stock ($0.001 Par Value) Underwriting Agreement
12/34/56
EX-1.1
from 8-K 33 pages Protalix Biotherapeutics, Inc. 4,000,000 Shares Common Stock ($0.001 Par Value) Underwriting Agreement
12/34/56
EX-1.1
from 8-K 30 pages Underwriting Agreement
12/34/56